- Type / Class
- Equity / Common Stock
- Shares outstanding
- 28,354,279
- Total 13F shares
- 1,278,400
- Share change
- +1,277,400
- Total reported value
- $4,646,000
- Price per share
- $3.59
- Number of holders
- 25
- Value change
- +$4,642,000
- Number of buys
- 24
Quarterly Holders Quick Answers
What is CUSIP 18507C103?
CUSIP 18507C103 identifies CLPT - ClearPoint Neuro, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q2 2020
Recent filing periods for CUSIP 18507C103:
Top shareholders of CLPT - ClearPoint Neuro, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
332,017
|
$1,593,000 | — | 31 Dec 2019 | |
| Merriman Wealth Management, LLC |
13F
|
Company |
0.34%
|
101,228
|
$486,000 | — | 31 Dec 2019 | |
| Worth Venture Partners, LLC |
13F
|
Company |
0.29%
|
86,725
|
$416,000 | — | 31 Dec 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.24%
|
71,473
|
$343,000 | — | 31 Dec 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.17%
|
50,750
|
$244,000 | — | 31 Dec 2019 | |
| Mayo Clinic |
13F
|
Company |
0.16%
|
47,148
|
$226,000 | — | 31 Dec 2019 | |
| KIRR MARBACH & CO LLC /IN/ |
13F
|
Company |
0.15%
|
44,200
|
$212,000 | — | 31 Dec 2019 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.09%
|
28,000
|
$134,000 | — | 31 Dec 2019 | |
| PARSONS CAPITAL MANAGEMENT INC/RI |
13F
|
Company |
0.09%
|
26,623
|
$128,000 | — | 31 Dec 2019 | |
| Williams Jones Wealth Management, LLC. |
13F
|
Company |
0.07%
|
21,552
|
$103,000 | — | 31 Dec 2019 | |
| WESTWOOD MANAGEMENT CORP /IL/ |
13F
|
Company |
0.06%
|
17,500
|
$84,000 | — | 31 Dec 2019 | |
| REGIONS FINANCIAL CORP |
13F
|
Company |
0.04%
|
11,655
|
$56,000 | — | 31 Dec 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
11,503
|
$55,000 | — | 31 Dec 2019 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
10,500
|
$50,000 | — | 31 Dec 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.03%
|
7,773
|
$37,000 | — | 31 Dec 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
3,000
|
$14,000 | — | 31 Dec 2019 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
2,938
|
$14,000 | — | 31 Dec 2019 | |
| Advisor Group, Inc. |
13F
|
Company |
0%
|
1,000
|
$5,000 | — | 31 Dec 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
500
|
$2,000 | — | 31 Dec 2019 | |
| OPTIMUM INVESTMENT ADVISORS |
13F
|
Company |
0%
|
437
|
$2,000 | — | 31 Dec 2019 |
Institutional Holders of ClearPoint Neuro, Inc. - Common Stock (CLPT) as of Q1 2020
As of 31 Mar 2020,
ClearPoint Neuro, Inc. - Common Stock (CLPT) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,278,400 shares.
The largest 10 holders included
VANGUARD GROUP INC, PARSONS CAPITAL MANAGEMENT INC/RI, EAM Investors, LLC, Merriman Wealth Management, LLC, Worth Venture Partners, LLC, MILLENNIUM MANAGEMENT LLC, Mayo Clinic, KIRR MARBACH & CO LLC /IN/, RENAISSANCE TECHNOLOGIES LLC, and BROWN ADVISORY INC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2020 vs Q4 2025 Across Filers
Q4 2025 holders
119
Q1 2020 holders
25
Holder diff
-94
| Investor | Q4 2025 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.